KR940014337A - 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제 - Google Patents
에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제 Download PDFInfo
- Publication number
- KR940014337A KR940014337A KR1019930029121A KR930029121A KR940014337A KR 940014337 A KR940014337 A KR 940014337A KR 1019930029121 A KR1019930029121 A KR 1019930029121A KR 930029121 A KR930029121 A KR 930029121A KR 940014337 A KR940014337 A KR 940014337A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- heterocycle
- aryl
- hydroxy
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
본 발명은 신규 HIV 프로테아제 억제제, 이러한 화합물을 함유한 약학적 제형, 및 HIV 감염 및/또는 AIDS의 치료 및/또는 예방법을 제공한다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 하기 일반식(Ⅰ)의 화합물 또는 그의 약학적으로 허용가능한 염 :상기식에서, R은 하기 일반식을 갖는 그룹이고 ;R2는 아미노산 측쇄 또는 -(CH2)y-X-R2a이고 ; y는 0, 1 또는 2이고 ; X는 결합, 이가(C2내지 C4)알케닐, 이가(C2내지 C4)알키닐, -C(O)-O-, -0-C(O)-, -C(O)-NR2b-, NR2b-C(O)-, -NR2b-, -C(O)-, -O-, -S-, -S(O)- 또는 -S(O)2- 이고 ; R2a는 아릴, 불포화 헤테로사이클, 헤테로사이클, 아릴(C1, 내지 C4)알킬, 불포화 헤테로사이클(C1내지 C4)알킬, 헤테로사이클(C1내지 C4)알킬, 테트라졸릴, N-(C1내지 C4)알킬테트라졸릴 또는 N-(아릴)테트라졸릴이고 ; R2b는 수소 또는 C1내지 C4알킬이고 ; R0는 수소, 카바모일, 포르밀, C2내지 C6알카노일, C1내지 C4알콕시카보닐, -C(O)CF3또는 -S(O)2-Z 이고 ; Z는 C1 내지 C6알킬, 아미노, C1내지 C4알킬아미노, 트리플루오로메틸 또는 디(C1내지 C4)알킬아미노이고; 비대칭 탄소 σ는 자연 발생적이 아닌 형태이고 ; R1는 아릴, C5내지 C7사이클로알킬 또는 -S-R1x(이때, R1x는 아릴 또는 C5내지 C7사이클로알킬이다)이고 ; A는 -CH2-또는이고 ; Y1은 헤테로사이클이고 ; R3은p는 4 또는 5이고 ; R4는 각각의 경우 독립적으로, 수소, C1내지 C6알킬 또는 하이드록시(C1내지 C4)알킬이고 ; R5및 R6은 독립적으로 수소, 하이드록시, C1내지 C6알킬, C1내지 C6알콕시, 아미노, C1내지 C4알킬아미노, 하이드록시(C1내지 C4)-알킬, 카복시, C1내지 C4알콕시카보닐, 카바모일, N-(C1내지 C4)알킬카바모일, 아릴, 헤테로사이클 또는 불포화 헤테로사이클 중에서 선택된다.
- 제 1 항에 있어서, R1a, Y1, R5또는 R6중 어느 하나가 헤테로사이클일 때, 헤테로사이클이 -(CH2)4-피리딜로 치환될 수 없는 화합물 또는 그의 약학적으로 허용되는 염.
- [2R-(2R*, 3S*, 6S*, 3'S*, 4a'S*, 8a'S*)]-N-(t-부틸)-2′-[2-하이드록시-3-페닐메틸-4-아자-5-옥소-6-N(메틸설포닐)-아미노-7-p-플루오로-페닐셜포닐]헵틸 데카하이드로이소퀴놀린-3'-카복스아미드 메탄설포네이트 ; 또는 [2R-(2R*, 3S*, 6S*, 3'S*, 4a'S*, 8a'S*)]-N-(t-부틸)-2′-[2-하이드록시-3-페닐메틸-4-아자-5-옥소-6-N(메틸설포닐9 아미노-7-나프트-2-일설포닐]헵틸 데카하이드로이소퀴놀린-3′-카복스아미드 또는 그의 약학적으로 허용되는 염.
- 제 1 내지 3항 중 어느 한 항에 청구된 일반식(Ⅰ)의 화합물 또는 그의 약학적으로 허용되는 염을 그에 대한 하나 이상의 약학적으로 허용되는 담체, 부형제 또는 희석제와 함께 포함하는 약학제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99525692A | 1992-12-22 | 1992-12-22 | |
US7/995,256 | 1992-12-22 | ||
US08/134,329 US5733906A (en) | 1993-10-12 | 1993-10-12 | Inhibitors of HIV Protease useful for the treatment of Aids |
US8/134,329 | 1993-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR940014337A true KR940014337A (ko) | 1994-07-18 |
Family
ID=26832220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930029121A KR940014337A (ko) | 1992-12-22 | 1993-12-22 | 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5905077A (ko) |
EP (1) | EP0604185B1 (ko) |
JP (1) | JPH06271534A (ko) |
KR (1) | KR940014337A (ko) |
CN (1) | CN1044117C (ko) |
AT (1) | ATE178055T1 (ko) |
AU (1) | AU667146B2 (ko) |
BR (1) | BR9305162A (ko) |
CA (1) | CA2112042A1 (ko) |
CZ (1) | CZ281493A3 (ko) |
DE (1) | DE69324120T2 (ko) |
ES (1) | ES2132201T3 (ko) |
FI (1) | FI935778A (ko) |
HU (1) | HUT69693A (ko) |
IL (1) | IL108092A (ko) |
MX (1) | MX9308016A (ko) |
MY (1) | MY131388A (ko) |
NO (1) | NO934719L (ko) |
NZ (1) | NZ250491A (ko) |
PL (1) | PL301581A1 (ko) |
TW (1) | TW262468B (ko) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USH1649H (en) | 1987-07-31 | 1997-05-06 | Barrish; Joel C. | HIV protease inhibitor combinations |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
RU2126794C1 (ru) | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы |
US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5461154A (en) * | 1994-02-02 | 1995-10-24 | Eli Lilly And Company | Intermediate and process for making |
TW472047B (en) * | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
ATE163642T1 (de) * | 1994-11-04 | 1998-03-15 | Yamakawa Chemical Ind | Verfahren zur herstellung von optisch aktiven piperazinderivaten und zwischenprodukten für ihre herstellung |
ES2167541T3 (es) * | 1995-02-03 | 2002-05-16 | Kaneka Corp | Procedimientos de produccion de alfa-halocetonas, de alfa-halohidrinas y de epoxidos. |
US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
US6222043B1 (en) | 1995-06-30 | 2001-04-24 | Japan Energy Corporation | Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof |
US5932550A (en) * | 1995-06-30 | 1999-08-03 | Japan Energy Corporation | Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
PT983999E (pt) * | 1995-09-26 | 2005-05-31 | Agouron Pharma | Processo para a producao de derivados amida e dos seus intermediarios |
JP3611332B2 (ja) * | 1995-09-26 | 2005-01-19 | 日本たばこ産業株式会社 | アミド誘導体の製造方法及び中間体化合物 |
ES2293651T3 (es) * | 1995-11-28 | 2008-03-16 | Cephalon, Inc. | Inhibidores de cisteina y serina proteasas derivados de aminoacidos d. |
US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
CA2249747A1 (en) | 1996-12-27 | 1998-07-09 | Tsutomu Mimoto | Novel tripeptide compounds and anti-aids drugs |
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
DK0950416T3 (da) | 1997-03-14 | 2007-02-26 | Daiichi Seiyaku Co | Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse |
US6538006B1 (en) * | 1998-07-08 | 2003-03-25 | Pharmacia Corporation | Retroviral protease inhibitors |
NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
BR9917082A (pt) * | 1998-12-24 | 2001-11-06 | Du Pont Pharm Co | Compostos inibidores da produção de proteìnas a"beta", método de tratamento de disfunções neurológicas associadas com a produção de "beta"-amilóide, composição farmacêutica e, método de inibição da atividade de y-secretase |
US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
US6503901B1 (en) | 1999-10-08 | 2003-01-07 | Bristol Myers Squibb Pharma Company | Amino lactam sulfonamides as inhibitors of Aβ protein production |
JP2003523345A (ja) | 2000-02-17 | 2003-08-05 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Aβタンパク質産生の阻害剤としてのスクシノイルアミノ炭素環および複素環 |
US6495540B2 (en) | 2000-03-28 | 2002-12-17 | Bristol - Myers Squibb Pharma Company | Lactams as inhibitors of A-β protein production |
MXPA02009729A (es) | 2000-04-03 | 2003-03-27 | Bristol Myers Squibb Pharma Co | Lactamas ciclicas como inhibidores de la produccion de la proteina a-beta. |
CN1436175A (zh) | 2000-04-03 | 2003-08-13 | 布里斯托尔-迈尔斯斯奎布药品公司 | 作为Aβ-蛋白生产抑制剂的环状内酰胺 |
US20100009966A1 (en) * | 2001-04-11 | 2010-01-14 | Bristol-Myers Squibb Pharma Company | Substituted lactams as inhibitors of abeta protein production |
WO2001077086A1 (en) * | 2000-04-11 | 2001-10-18 | Dupont Pharmaceuticals Company | SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
US6878363B2 (en) * | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
WO2001092235A1 (en) | 2000-06-01 | 2001-12-06 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
GB0028483D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Hydroxyethylamine HIV protease inhibitors |
JPWO2002064553A1 (ja) * | 2001-02-14 | 2004-06-10 | 呉羽化学工業株式会社 | ハロゲノアルコール誘導体の製造方法 |
US20090062256A1 (en) * | 2001-06-01 | 2009-03-05 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
GB0123467D0 (en) | 2001-09-28 | 2001-11-21 | Hoffmann La Roche | Carbocyclic HIV Protease inhibitors |
KR101155335B1 (ko) * | 2005-01-07 | 2012-06-11 | 엘지전자 주식회사 | 이동통신 단말기의 멀티미디어 메시지 동작방법 |
ES2426345T3 (es) | 2005-07-20 | 2013-10-22 | Eli Lilly And Company | Compuesto unidos en posición 1-amino |
CN101508664B (zh) * | 2009-02-25 | 2012-08-22 | 江阴希迪医药科技有限公司 | N-苄氧羰基-3-氨基-1-氯-4-苯硫基-2-丁醇合成方法 |
JP5984218B2 (ja) | 2010-07-02 | 2016-09-06 | ギリアード サイエンシーズ, インコーポレイテッド | Aidsを処置するためのナフト−2−イル酢酸誘導体 |
US9296758B2 (en) | 2010-07-02 | 2016-03-29 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds |
US9006229B2 (en) | 2011-04-21 | 2015-04-14 | Gilead Sciences, Inc. | Benzothiazole compounds and their pharmaceutical use |
US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
WO2013103738A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
EP3070081B1 (en) | 2012-04-20 | 2018-02-28 | Gilead Sciences, Inc. | Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
CA2096525C (en) | 1990-11-19 | 2005-02-08 | Deborah Elizabeth Bertenshaw | Retroviral protease inhibitors |
CA2060844A1 (en) * | 1991-02-08 | 1992-08-09 | Yabe Yuichiro | Beta-amino-alpha-hydroxycarboxylic acids and their use |
US5430041A (en) * | 1991-05-10 | 1995-07-04 | Hoffmann-La Roche Inc. | Amino acid derivatives having antiviral activity |
CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
WO1993013066A1 (en) | 1991-12-20 | 1993-07-08 | Syntex (U.S.A.) Inc. | Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors |
US5312820A (en) * | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
-
1993
- 1993-12-15 MX MX9308016A patent/MX9308016A/es not_active IP Right Cessation
- 1993-12-17 NZ NZ250491A patent/NZ250491A/en unknown
- 1993-12-17 CZ CZ932814A patent/CZ281493A3/cs unknown
- 1993-12-17 MY MYPI93002745A patent/MY131388A/en unknown
- 1993-12-20 DE DE69324120T patent/DE69324120T2/de not_active Expired - Fee Related
- 1993-12-20 EP EP93310359A patent/EP0604185B1/en not_active Expired - Lifetime
- 1993-12-20 AT AT93310359T patent/ATE178055T1/de not_active IP Right Cessation
- 1993-12-20 AU AU52528/93A patent/AU667146B2/en not_active Ceased
- 1993-12-20 ES ES93310359T patent/ES2132201T3/es not_active Expired - Lifetime
- 1993-12-20 HU HU9303679A patent/HUT69693A/hu unknown
- 1993-12-20 IL IL108092A patent/IL108092A/en active IP Right Grant
- 1993-12-20 NO NO934719A patent/NO934719L/no unknown
- 1993-12-20 PL PL93301581A patent/PL301581A1/xx unknown
- 1993-12-21 BR BR9305162A patent/BR9305162A/pt not_active Application Discontinuation
- 1993-12-21 CN CN93112962A patent/CN1044117C/zh not_active Expired - Fee Related
- 1993-12-21 CA CA002112042A patent/CA2112042A1/en not_active Abandoned
- 1993-12-21 FI FI935778A patent/FI935778A/fi not_active Application Discontinuation
- 1993-12-21 JP JP5322750A patent/JPH06271534A/ja active Pending
- 1993-12-22 KR KR1019930029121A patent/KR940014337A/ko active IP Right Grant
- 1993-12-22 TW TW082110893A patent/TW262468B/zh active
-
1997
- 1997-11-19 US US08/974,430 patent/US5905077A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0604185A1 (en) | 1994-06-29 |
DE69324120D1 (de) | 1999-04-29 |
DE69324120T2 (de) | 1999-11-25 |
HUT69693A (en) | 1995-09-28 |
IL108092A (en) | 1998-06-15 |
CZ281493A3 (en) | 1994-07-13 |
AU5252893A (en) | 1994-07-07 |
NO934719L (no) | 1994-06-23 |
US5905077A (en) | 1999-05-18 |
FI935778A0 (fi) | 1993-12-21 |
CN1044117C (zh) | 1999-07-14 |
EP0604185B1 (en) | 1999-03-24 |
NZ250491A (en) | 1995-08-28 |
AU667146B2 (en) | 1996-03-07 |
JPH06271534A (ja) | 1994-09-27 |
CA2112042A1 (en) | 1994-06-23 |
MX9308016A (es) | 1994-08-31 |
MY131388A (en) | 2007-08-30 |
CN1094399A (zh) | 1994-11-02 |
ATE178055T1 (de) | 1999-04-15 |
ES2132201T3 (es) | 1999-08-16 |
BR9305162A (pt) | 1994-11-01 |
FI935778A (fi) | 1994-06-23 |
TW262468B (ko) | 1995-11-11 |
IL108092A0 (en) | 1994-04-12 |
PL301581A1 (en) | 1994-06-27 |
NO934719D0 (no) | 1993-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940014337A (ko) | 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제 | |
DK0727419T3 (da) | Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease | |
RU96109378A (ru) | Ингибиторы протеазы вич | |
BR1100970A (pt) | Composto, e, composição farmacêutica útil no tratamento de doença cardiovascular, tal como hipertensão e deficiência cardìaca congestiva | |
PE20011022A1 (es) | Compuestos trans olefinicos activadores glucoquinasa | |
MA27002A1 (fr) | Amides d'acide anthranilique, procede pour les preparer, leur utilisation comme antiarythmiques et preparations pharmaceutiques les contenant | |
IL205420A0 (en) | Immunoregulatory compounds and derivatives | |
RU94035686A (ru) | 4-ариламино-бензопиран и родственные соединения, фармацевтическая композиция, способ лечения | |
ES2148254T3 (es) | Peptidos antimicrobianos ciclicos y preparacion de los mismos. | |
NO962748D0 (no) | Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og medisinsk anvendelse derav | |
EA200200831A1 (ru) | Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой | |
KR920018028A (ko) | 콜레스테롤 생합성 억제제로서의 신규 아자데칼린 아미드 및 티오아미드 | |
KR940014336A (ko) | 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제 | |
DK319886A (da) | Kemiske forbindelser | |
RU2218334C2 (ru) | Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе | |
DK0630252T3 (da) | Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme | |
ATE253359T1 (de) | Antithrombotische mittel | |
KR930021616A (ko) | (1h-인돌-1-일)-2-(아미노)아세트아미드 및 관련 (1h-인돌-1-일)-(아미노알킬)아미드, 이를 제조하기 위한 중간체 및 제조방법, 및 약제로서의 이의 용도 | |
IT1214618B (it) | Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche. | |
DE69925250D1 (de) | Aktivatoren der kalium-kanäle | |
DE69827614D1 (de) | Chinoxalindionen | |
ES2169909T3 (es) | 5-hidroximetil-2-aminotetralinas como agentes cardiovasculares. | |
KR910000645A (ko) | 개선된 경련치료제 | |
ATE56967T1 (de) | Amidderivate. | |
ATE53385T1 (de) | Sulfinyl- und sulfonylsubstituierte 3benzazepine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |